SAB Biotherapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $83.9M
Liabilities Breakdown FY2023
Total Liabilities: $26.6M
Asset Breakdown
Total Assets: $83.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $56.6M | 67.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $19.7M | 23.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $7.6M | 9.1% |
Liabilities Breakdown
Total Liabilities: $26.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $945.9K | 3.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $25.7M | 96.4% |